These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 32764884

  • 1. Tanshinone IIA Ameliorates Progression of CAD Through Regulating Cardiac H9c2 Cells Proliferation and Apoptosis by miR-133a-3p/EGFR Axis.
    Xu H, Li H, Zhu P, Liu Y, Zhou M, Chen A.
    Drug Des Devel Ther; 2020; 14():2853-2863. PubMed ID: 32764884
    [Abstract] [Full Text] [Related]

  • 2. Benzodiazepines safeguards nerve cells from the toxicity of lidocaine via miR-133a-3p/EGFR pathway.
    Li Y, Yi L, Li X, Li Y.
    Transpl Immunol; 2022 Apr; 71():101510. PubMed ID: 34856331
    [Abstract] [Full Text] [Related]

  • 3. Tanshinone IIA Regulates MAPK/mTOR Signal-Mediated Autophagy to Alleviate Atherosclerosis through the miR-214-3p/ATG16L1 Axis.
    Qian Y, He Y, Qiong A, Zhang W.
    Int Heart J; 2023 Apr; 64(5):945-954. PubMed ID: 37778998
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury through the PI3K/Akt/eNOS pathway by sponging miRNA-133a-3p to target IGF1R expression.
    Liu XM, Zhang Z, Zhong J, Li N, Wang T, Wang L, Zhang Q.
    Eur J Pharmacol; 2022 Feb 05; 916():174719. PubMed ID: 34968461
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA attenuates high glucose induced human VSMC proliferation and migration through miR-21-5p-mediated tropomyosin 1 downregulation.
    Jia S, Ma WD, Zhang CY, Zhang Y, Yao ZH, Quan XH, Guo X, Wang CX.
    Arch Biochem Biophys; 2019 Nov 30; 677():108154. PubMed ID: 31672498
    [Abstract] [Full Text] [Related]

  • 6. MiR-133a-3p inhibits the malignant progression of oesophageal cancer by targeting CDCA8.
    Wang X, Zhu L, Lin X, Huang Y, Lin Z.
    J Biochem; 2022 Jan 07; 170(6):689-698. PubMed ID: 34117764
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway.
    Huang Y, Wang Y, Lin L, Wang P, Jiang L, Liu J, Wang X.
    Mol Cell Probes; 2020 Aug 07; 52():101563. PubMed ID: 32205184
    [Abstract] [Full Text] [Related]

  • 8. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
    Liu C, Li J, Wang L, Wu F, Huang L, Xu Y, Ye J, Xiao B, Meng F, Chen S, Yang M.
    BMC Complement Altern Med; 2012 Jan 16; 12():5. PubMed ID: 22248096
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of Tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress.
    Xie Z, Zhou Y, Duan X, Yang L.
    J Recept Signal Transduct Res; 2019 Apr 16; 39(2):134-145. PubMed ID: 31354004
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA inhibits the adipogenesis and inflammatory response in ox-LDL-challenged human monocyte-derived macrophages via regulating miR-130b/WNT5A.
    Yuan L, Li Q, Zhang Z, Liu Q, Wang X, Fan L.
    J Cell Biochem; 2020 Feb 16; 121(2):1400-1408. PubMed ID: 31512787
    [Abstract] [Full Text] [Related]

  • 11. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
    Yin Y, Du L, Li X, Zhang X, Gao Y.
    J Cell Physiol; 2019 Aug 16; 234(8):12757-12770. PubMed ID: 30537034
    [Abstract] [Full Text] [Related]

  • 12. Tanshinone IIA Ameliorates Inflammation Response in Osteoarthritis via Inhibition of miR-155/FOXO3 Axis.
    Zhou B, Li LH, Tan LM, Luo WB, Xiong H, Lu XL, Liu D, Li WY, Guo YX, Tang Z, Zhu LG.
    Pharmacology; 2021 Aug 16; 106(1-2):20-28. PubMed ID: 33395681
    [Abstract] [Full Text] [Related]

  • 13. Tanshinone IIA from Salvia miltiorrhiza exerts anti-fibrotic effects on cardiac fibroblasts and rat heart tissues by suppressing the levels of pro-fibrotic factors: The key role of miR-618.
    Yan N, Xiao C, Wang X, Xu Z, Yang J.
    J Food Biochem; 2022 Feb 16; 46(2):e14078. PubMed ID: 35014054
    [Abstract] [Full Text] [Related]

  • 14. Tanshinone IIA reverses gefitinib resistance in EGFR-mutant lung cancer via inhibition of SREBP1-mediated lipogenesis.
    Zhang L, Xu C, Huang J, Jiang S, Qin Z, Cao L, Tan G, Zhao Z, Huang M, Jin J.
    Phytother Res; 2024 Mar 16; 38(3):1574-1588. PubMed ID: 38282115
    [Abstract] [Full Text] [Related]

  • 15. Tanshinone ⅡA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling.
    Li Y, Chen F, Guo R, Jia S, Li W, Zhang B.
    Biochem Biophys Res Commun; 2020 Jan 29; 522(1):157-163. PubMed ID: 31757424
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA MSTRG.5970.28 regulates proliferation and apoptosis of goose follicle granulosa cells via the miR-133a-3p/ANOS1 pathway.
    Zhao X, Li H, Chen X, Wu Y, Wang L, Li J.
    Poult Sci; 2023 Mar 29; 102(3):102451. PubMed ID: 36634463
    [Abstract] [Full Text] [Related]

  • 17. Tanshinone IIA improves cardiac function via regulating miR-499-5p dependent angiogenesis in myocardial ischemic mice.
    Wang X, Wu C.
    Microvasc Res; 2022 Sep 29; 143():104399. PubMed ID: 35697130
    [Abstract] [Full Text] [Related]

  • 18. Effect of microRNA-133a-3p/matrix metalloproteinase-9 axis on the growth of atherosclerotic vascular smooth muscle cells.
    Shi L, Yu C, Tian X, Ma C, Wang L, Xia D, Cui C, Chen X, Jiang T, Gu Y, Liu Z, Cai S.
    Exp Ther Med; 2019 Dec 29; 18(6):4356-4362. PubMed ID: 31772631
    [Abstract] [Full Text] [Related]

  • 19. Downregulating LncRNA XIST attenuated contrast-induced nephropathy injury via regulating miR-133a-3p/NLRP3 axis.
    Liu X, Song W, Zhang X, Long F, Yin J, He X, Lv L.
    J Thromb Thrombolysis; 2021 Aug 29; 52(2):440-453. PubMed ID: 33387208
    [Abstract] [Full Text] [Related]

  • 20. LncRNA PVT1 inhibits endothelial cells apoptosis in coronary heart disease through regulating MAPK1 expression via miR-532-3p.
    Liu H, Ma XF, Dong N, Wang GN, Qi MX, Tan JK.
    Acta Cardiol; 2024 May 29; 79(3):295-303. PubMed ID: 37260124
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.